BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10333478)

  • 1. Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids.
    Hahnel D; Huber T; Kurze V; Beyer K; Engelmann B
    Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):377-83. PubMed ID: 10333478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and alpha-tocopherol.
    Hahnel D; Beyer K; Engelmann B
    Free Radic Biol Med; 1999 Nov; 27(9-10):1087-94. PubMed ID: 10569641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
    Burkitt MJ
    Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro.
    Reiss D; Beyer K; Engelmann B
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):807-14. PubMed ID: 9169616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of plasmalogens in the enhanced resistance of LDL to copper-induced oxidation after LDL apheresis.
    Hahnel D; Thiery J; Brosche T; Engelmann B
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2431-8. PubMed ID: 10521373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of plasmalogen in the oxidative stability of neutral lipids and phospholipids.
    Wang G; Wang T
    J Agric Food Chem; 2010 Feb; 58(4):2554-61. PubMed ID: 20099826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cu(I) availability paradoxically antagonizes antioxidant consumption and lipid peroxidation during the initiation phase of copper-induced LDL oxidation.
    Bagnati M; Bordone R; Perugini C; Cau C; Albano E; Bellomo G
    Biochem Biophys Res Commun; 1998 Dec; 253(2):235-40. PubMed ID: 9878521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins.
    Engelmann B; Bräutigam C; Thiery J
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1235-42. PubMed ID: 7980601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of low density lipoproteins leads to disturbance of their binding with alpha-tocopherol.
    Bakalova RA; Goudev AR; Zhelev ZZ; Nachev C; Ribarov SR
    Gen Physiol Biophys; 1996 Dec; 15(6):463-75. PubMed ID: 9248832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens.
    Jürgens G; Fell A; Ledinski G; Chen Q; Paltauf F
    Chem Phys Lipids; 1995 Aug; 77(1):25-31. PubMed ID: 7586089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the kinetics of low-density lipoprotein oxidation induced by copper or by gamma-rays: influence of radiation dose-rate and copper concentration.
    Khalil A; Fülöp T
    Can J Physiol Pharmacol; 2001 Feb; 79(2):114-21. PubMed ID: 11233561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for apo B-100-mediated copper reduction: studies with purified apo B-100 and detection of tryptophanyl radicals.
    Batthyány C; Santos CX; Botti H; Cerveñansky C; Radi R; Augusto O; Rubbo H
    Arch Biochem Biophys; 2000 Dec; 384(2):335-40. PubMed ID: 11368321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ursodeoxycholic acid on copper induced oxidation of low density lipoprotein.
    Geetha A; Surendran R
    Pharmazie; 2005 Aug; 60(8):609-13. PubMed ID: 16124405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmalogens: targets for oxidants and major lipophilic antioxidants.
    Engelmann B
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):147-50. PubMed ID: 14748736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein.
    Kuzuya M; Yamada K; Hayashi T; Funaki C; Naito M; Asai K; Kuzuya F
    Biochim Biophys Acta; 1992 Feb; 1123(3):334-41. PubMed ID: 1536873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of human HDL against Cu(2+)-induced oxidation of astrocytes.
    Ferretti G; Bacchetti T; Moroni C; Vignini A; Curatola G
    J Trace Elem Med Biol; 2003; 17 Suppl 1():25-30. PubMed ID: 14650625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative time-courses of copper-ion-mediated protein and lipid oxidation in low-density lipoprotein.
    Knott HM; Baoutina A; Davies MJ; Dean RT
    Arch Biochem Biophys; 2002 Apr; 400(2):223-32. PubMed ID: 12054433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the antioxidant to pro-oxidant switch in the behavior of dehydroascorbate during LDL oxidation by copper(II) ions.
    Horsley ET; Burkitt MJ; Jones CM; Patterson RA; Harris LK; Moss NJ; del Rio JD; Leake DS
    Arch Biochem Biophys; 2007 Sep; 465(2):303-14. PubMed ID: 17689484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health.
    Piolot A; Blache D; Boulet L; Fortin LJ; Dubreuil D; Marcoux C; Davignon J; Lussier-Cacan S
    J Lab Clin Med; 2003 Jan; 141(1):41-9. PubMed ID: 12518167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide inhibits prooxidant actions of uric acid during copper-mediated LDL oxidation.
    Sanguinetti SM; Batthyány C; Trostchansky A; Botti H; López GI; Wikinski RL; Rubbo H; Schreier LE
    Arch Biochem Biophys; 2004 Mar; 423(2):302-8. PubMed ID: 15001394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.